阿立哌唑联合利培酮治疗慢性精神分裂症的疗效探讨
2020-09-15孙晓婧潘洁
孙晓婧 潘洁


【摘 要】 目的:探讨阿立哌唑联合利培酮治疗慢性精神分裂症的疗效。方法:选取2018年10月-2019年9月入住我院的慢性精神分裂症患者92例,应用数字法随机分为两组,每组均为46例,对照组应用利培酮为患者实施治疗,研究组应用阿立哌唑联合利培酮为患者实施治疗。结果:研究组疗效优于对照组(P<0.05),研究组治疗后的PANSS评分低于对照组(P<0.05),研究组的不良反应率低于对照组(P<0.05)。结论:阿立哌唑联合利培酮对慢性精神分裂症患者实施治疗,属于较为科学治疗措施,治疗效果极为理想,且患者在治疗中的不良反应发生率相对较低,这说明药物联合应用更具有安全性,更利于患者病情的恢复,值得应用推广。
【关键词】 阿立哌唑;联合;利培酮;治疗;慢性精神分裂症
【中图分类号】 R197.6 【文獻标志码】A 【文章编号】1005-0019(2020)17-022-01
Abstract:Objective:To investigate the efficacy of aripiprazole combined with risperidone in the treatment of chronic schizophrenia. Methods:92 patients with chronic schizophrenia admitted to our hospital from October 2018 to September 2019 were randomly divided into two groups with 46 cases in each group by digital method. The control group was treated with risperidone, while the study group was treated with aripiprazole combined with risperidone. Results:the curative effect of the study group was better than that of the control group (p < 0.05), the PANSS score of the study group after treatment was lower than that of the control group (p < 0.05), and the adverse reaction rate of the study group was lower than that of the control group (p < 0.05). Conclusion:Aripiprazole combined with risperidone is a scientific treatment measure for patients with chronic schizophrenia. The therapeutic effect is extremely ideal, and the incidence of adverse reactions in patients is relatively low. This shows that the combined application of drugs is more safe, more conducive to the recovery of patients' condition, and worthy of application and promotion.
Key words:aripiprazole; Union; Risperidone; Treatment; Chronic schizophrenia
精神分裂症属于精神科的慢性重性的精神疾病,其在临床比较常见。在对患者实施治疗时不同的药物,会对患者的内分泌以及机体的代谢造成不同的影响[1]。有关资料显示,应用阿立哌唑来对精神分裂症患者进行治疗在改善其症状的同时还可以帮助患者降低药物对其机体的糖脂代谢所产生的影响[2]。本次主要探究,应用阿立哌唑联合利培酮对慢性精神分裂症患者实施治疗的效果,结果如下。
1 资料与方法
1.1 一般资料 选取2018年10月-2019年9月入住我院的慢性精神分裂症患者92例,分为两组,每组均为46例,对照组男25例,女21例;年龄25-44岁,平均(34.5±1.9)岁;病程1.2-5年,平均(3.1±1.2)年。研究组男27例,女19例; 年龄24-47岁,平均(35.5±1.8)岁;病程1-5.6年,平均(3.3±1.5)年。两组患者资料无可比性差异(P>0.05)。
1.2 方法
1.2.1 对照组 给予患者应用利培酮进行治疗,初始每日口服1mg,之后依据患者的实际症状进行剂量的调整,每天最大剂量不超过4-6mg,连续治疗8周。
1.2.2 研究组 给予患者应用利培酮联合阿立哌唑进行治疗,利培酮最初每天应用1mg,待增至每天2mg后,加用阿立哌唑,初始剂量每天5mg,之后可逐步调整剂量,每天在20mg-25mg之间,利培酮剂量每天不超过4mg,治疗8周。……p>
